Brief diagram of the proposed therapeutic effect of the LiESWT in improving detrusor hyperactivity via TRPV channels and the cellular signaling pathway involved in regulating intracellular Ca2+ oscillation in a rat model of OHD-induced DHIC

A brief diagram of the proposed therapeutic effect of the LiESWT in improving detrusor hyperactivity via TRPV channels and the cellular signaling pathway involved in regulating intracellular Ca2+ oscillation in a rat model of OHD-induced DHIC. The OVX-treated rat model was used to mimic the physiological conditions of OHD or the postmenopausal state to induce detrusor hyperactivity symptoms. LiESWT (0.12 mJ/mm2, 300 impulses, 3 Hz) was applied to the lower abdomen of the OHD-induced DHIC rats. Accordingly, the OVX rats had exacerbated pathological damage in the bladder and worse bladder contractile responses, while the LiESWT ameliorated OVX-induced detrusor hyperactivity and improved the bladder contractile function. Additionally, the neurogenesis effect of the LiESWT increased the levels of neurogenesis (NF, NeuN, and GFAP), muscarinic receptors (M2 and M3), purinergic receptor (P2X7), TRPV channels (TRPV1 and TRPV4), ER stress proteins (CHOP, GRP78, and caspase 12), ER-related Ca2+ channels/receptors (RyR, IP3R, and SERCA), and Ano1 that were involved in regulating intracellular Ca2+ oscillation. Meanwhile, the LiESWT treatment significantly enhanced the signaling-pathway-related proteins, including Gq/11, Gq/12, Gq/13, RhoA, and RhoK, in the bladder involved in the activation of ER-related Ca2+ channels/receptors. Therefore, the OVX rats had worse bladder contractile responses that caused bladder contractile deficiency in a rat model of OHD-induced DHIC, while the LiESWT reduced the detrusor hyperactivity and ameliorated the bladder contractile function. The above findings imply that the OHD status after 12 months of OVX resulted in neuronal degeneration and decreased activation of the TRPV1 and TRPV4 channels in a rat model of OHD-induced DHIC. Ach, acetylcholine; DHIC, detrusor hyperactivity with impaired contractility; ER, endoplasmic reticulum; IP3, inositol trisphosphate; IP3R, inositol trisphosphate receptor; LiESWT, low-intensity extracorporeal shock wave therapy; M2/M3, muscarinic receptors; OHD, ovary hormone deficiency; P2X7, purinergic receptor; PKG, protein kinase G; RhoA, ras homolog family member A; RhoK, Rho-associated protein kinase; RyR, ryanodine receptor; SERCA, sarcoplasmic/endoplasmic reticulum Ca-ATPase; TRPV, transient receptor potential vanilloid
Brief diagram of the proposed therapeutic effect of the LiESWT in improving detrusor hyperactivity via TRPV channels and the cellular signaling pathway involved in regulating intracellular Ca2+ oscillation in a rat model of OHD-induced DHIC

Publication

Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency (2024) Kuang-Shun Chueh, et al. Int J Mol Sci. 2024 May;25(9). Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates mm2 MM2 ncbigene_synonym PNMA2 10687
Homo sapiens Primates P2X7 P2X7 ncbigene_synonym P2RX7 5027
Homo sapiens Primates Ach ACH ncbigene_synonym FGFR3 2261
Homo sapiens Primates PKG PKG ncbigene_synonym PRKG1 5592
Homo sapiens Primates SERCA SERCA famplex_relations ATP2A1 487
Homo sapiens Primates SERCA SERCA famplex_relations ATP2A2 488
Homo sapiens Primates SERCA SERCA famplex_relations ATP2A3 489
Homo sapiens Primates Gq/11 GQ famplex_relations GNAQ 2776
Homo sapiens Primates Gq/11 GQ famplex_relations GNA11 2767
Homo sapiens Primates Gq/11 GQ famplex_relations GNA14 9630
Homo sapiens Primates Gq/11 GQ famplex_relations GNA15 2769
Homo sapiens Primates TRPV1 TRPV1 ncbigene_symbol TRPV1 7442
Homo sapiens Primates TRPV4 TRPV4 ncbigene_symbol TRPV4 59341
Homo sapiens Primates PLC PLC ncbigene_synonym HSPG2 3339
Homo sapiens Primates PLC PLC famplex_relations PLCE1 51196
Homo sapiens Primates PLC PLC famplex_relations PLCZ1 89869
Homo sapiens Primates PLC PLC famplex_relations PLCB1 23236
Homo sapiens Primates PLC PLC famplex_relations PLCB2 5330
Homo sapiens Primates PLC PLC famplex_relations PLCB3 5331
Homo sapiens Primates PLC PLC famplex_relations PLCB4 5332
Homo sapiens Primates PLC PLC famplex_relations PLCD1 5333
Homo sapiens Primates PLC PLC famplex_relations PLCD3 113026
Homo sapiens Primates PLC PLC famplex_relations PLCD4 84812
Homo sapiens Primates PLC PLC famplex_relations PLCG1 5335
Homo sapiens Primates PLC PLC famplex_relations PLCG2 5336
Homo sapiens Primates IP3R IP3R ncbigene_synonym ITPR1 3708
Homo sapiens Primates IP3R IP3R ncbigene_synonym ITPR3 3710
Homo sapiens Primates RyR RYR ncbigene_synonym RYR1 6261
Homo sapiens Primates RyR RYR ncbigene_synonym RYR2 6262
Homo sapiens Primates RyR RYR famplex_relations RYR3 6263
Homo sapiens Primates Gap GAP ncbigene_synonym RASA1 5921
Homo sapiens Primates Gap GAP ncbigene_synonym RGS6 9628
Homo sapiens Primates G12 G12 famplex_relations GNA12 2768
Homo sapiens Primates G12 G12 famplex_relations GNA13 10672
Homo sapiens Primates G12/13 G13 ncbigene_synonym ATF6B 1388
Homo sapiens Primates RhoA RHOA ncbigene_symbol RHOA 387
Homo sapiens Primates Rhok RHOK ncbigene_synonym GRK1 6011

Chemical mentions

Word Match MeSH Name ChEBI
Ca2+ Ca2+ Ca(2+) chebi:29108
Nucleus nucleus nucleus chebi:33252
Ca2+ Ca2+ Ca(2+) chebi:29108
Ach ACh 2-acetyloxy-N,N,N-trimethylethanaminium chebi:15355
SERCA SerCA L-serocholate chebi:229711
Ach ACh 2-acetyloxy-N,N,N-trimethylethanaminium chebi:15355
Nucleus nucleus nucleus chebi:33252
Ca2+ Ca2+ Ca(2+) chebi:29108
Ach ACh 2-acetyloxy-N,N,N-trimethylethanaminium chebi:15355
Nucleus nucleus nucleus chebi:33252

Disease mentions

Word Match MeSH Name DOID